BIMI International Medical Inc.
BIMI · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $11,830 | $21,320 | $12,845 | $158 |
| % Growth | -44.5% | 66% | 8,030.9% | – |
| Cost of Goods Sold | $9,880 | $18,894 | $10,402 | $304 |
| Gross Profit | $1,950 | $2,426 | $2,443 | -$146 |
| % Margin | 16.5% | 11.4% | 19% | -92.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $10,600 | $6,057 | $5,472 | $986 |
| SG&A Expenses | $11,903 | $8,210 | $6,255 | $986 |
| Sales & Mktg Exp. | $1,303 | $2,153 | $783 | $0 |
| Other Operating Expenses | $5,385 | $0 | $0 | $581 |
| Operating Expenses | $17,288 | $8,210 | $6,255 | $1,567 |
| Operating Income | -$15,338 | -$8,107 | -$3,812 | -$986 |
| % Margin | -129.7% | -38% | -29.7% | -624.1% |
| Other Income/Exp. Net | -$6,284 | -$26,557 | $461 | -$550 |
| Pre-Tax Income | -$21,622 | -$34,664 | -$3,352 | -$1,536 |
| Tax Expense | $6 | $30 | $434 | $0 |
| Net Income | -$22,393 | -$34,986 | -$5,293 | -$4,439 |
| % Margin | -189.3% | -164.1% | -41.2% | -2,809.9% |
| EPS | -8.4 | -65.1 | -24.8 | -27.5 |
| % Growth | 87.1% | -162.5% | 9.8% | – |
| EPS Diluted | -8.4 | -65.1 | -24.8 | -27.5 |
| Weighted Avg Shares Out | 2,665 | 536 | 213 | 163 |
| Weighted Avg Shares Out Dil | 2,665 | 536 | 213 | 163 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $3 | $0 | $0 |
| Interest Expense | $3,431 | $2,443 | $85 | $6 |
| Depreciation & Amortization | $224 | $244 | $56 | $262 |
| EBITDA | -$17,967 | -$31,977 | -$3,211 | -$1,268 |
| % Margin | -151.9% | -150% | -25% | -802.7% |